High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinomaKUVAJA, Paula; TALVENSAARI-MATTILA, Anne; TURPEENNIEMI-HUJANEN, Taina et al.International journal of cancer. 2008, Vol 123, Num 4, pp 846-851, issn 0020-7136, 6 p.Article

Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: A potential marker for prognosisRUOKOLAINEN, Henni; PÄÄKKÖ, Paavo; TURPEENNIEMI-HUJANEN, Taina et al.Clinical cancer research. 2004, Vol 10, Num 9, pp 3110-3116, issn 1078-0432, 7 p.Article

Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomasKUITTINEN, Outi; APAJA-SARKKINEN, Meeri; TURPEENNIEMI-HUJANEN, Taina et al.European journal of haematology. 2003, Vol 71, Num 2, pp 91-99, issn 0902-4441, 9 p.Article

Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic markerRUOKOLALAINEN, Henni; PÄÄKKÖ, Paavo; TURPEENNIEMI-HUJANEN, Taina et al.International journal of cancer. 2005, Vol 116, Num 3, pp 422-427, issn 0020-7136, 6 p.Article

Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: Comparison of the circulating and Tissue immunoreactive proteinRUOKOLAINEN, Henni; PÄÄKKÖ, Paavo; TURPEENNIEMI-HUJANEN, Taina et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3257-3264, issn 1078-0432, 8 p.Article

Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancerVASALA, Kaija; PÄÄKKO, Paavo; TURPEENNIEMI-HUJANEN, Taina et al.Urology (Ridgewood, NJ). 2003, Vol 62, Num 5, pp 952-957, issn 0090-4295, 6 p.Article

The absence of immunoreactivity for tissue inhibitor of metalloproteinase-1 (TIMP-1), but not for TIMP-2, protein is associated with a favorable prognosis in aggressive breast carcinomaKUVAJA, Paula; TALVENSAARI-MATTILA, Anne; PÄÄKKÖ, Paavo et al.Oncology. 2005, Vol 68, Num 2-3, pp 196-203, issn 0030-2414, 8 p.Article

Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumoursMAATTA, Milla; TALVENSAARI-MATTILA, Anne; TURPEENNIEMI-HUJANEN, Taina et al.Anticancer research. 2007, Vol 27, Num 4C, pp 2753-2758, issn 0250-7005, 6 p.Article

Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinomaKUVAJA, Paula; TALVENSAARI-MATTILA, Anne; PÄÄKKÖ, Paavo et al.Human pathology. 2006, Vol 37, Num 10, pp 1316-1323, issn 0046-8177, 8 p.Article

Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinomaMÄÄTTÄ, Milla; SANTALA, Markku; SOINI, Ylermi et al.Acta obstetricia et gynecologica scandinavica. 2010, Vol 89, Num 3, pp 380-384, issn 0001-6349, 5 p.Article

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancerSIVULA, Anna; TALVENSAARI-MATTILA, Anne; LUNDIN, Johan et al.Breast cancer research and treatment. 2005, Vol 89, Num 3, pp 215-220, issn 0167-6806, 6 p.Article

Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancerYLISIRNIÖ, Sanna; HÖYHTYÄ, Matti; MÄKITARO, Riitta et al.Clinical cancer research. 2001, Vol 7, Num 6, pp 1633-1637, issn 1078-0432Article

Biological roles and prognostic values of the epithelial―mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphomaLEMMA, Siria; KARIHTALA, Peeter; HAAPASAARI, Kirsi-Maria et al.Histopathology. 2013, Vol 62, Num 2, pp 326-333, issn 0309-0167, 8 p.Article

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer TrialJOENSUU, Heikki; BONO, Petri; HELLE, Leena et al.Journal of clinical oncology. 2009, Vol 27, Num 34, pp 5685-5692, issn 0732-183X, 8 p.Article

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancerJOENSUU, Heikki; KELLOKUMPU-LEHTINEN, Pirkko-Liisa; TURPEENNIEMI-HUJANEN, Taina et al.The New England journal of medicine. 2006, Vol 354, Num 8, pp 809-820, issn 0028-4793, 12 p.Article